Smith & Nephew plc (SNN:NYSE) closed at $30.24 on November 2, 2026, up 1.82% on the day. The stock trades 18.5% below its 52-week high of $37.09 and 15.8% above its 52-week low of $26.12. Over the past year, it lost 17.8%. Smith & Nephew plc is part of the Health Care sector (Industrial Specialties).
In 252 trading sessions since October 31, 2025, SNN closed higher on 115 days (46%). Its best day was October 22, 2026 (+5.64%) and its worst was November 6, 2025 (-11.72%). The stock moved 10% or more in a single session 1 time.
Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints; and arthroscopic enabling technologies for healthcare providers, such as fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency wands, electromechanical and mechanical blades, and hand instruments for removing damaged tissue. It also provides trauma and extremities products consisting of internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery products and services; knee implant products for specialized knee replacement procedures; and hip implant products for reconstruction of the hip joint, as well as various products and technologies to assist in surgical treatment of the ear, nose, and throat. In addition, the company offers advanced wound care products for the treatment of acute and chronic w...
Find more stocks like SNN with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.